<DOC>
	<DOCNO>NCT00509106</DOCNO>
	<brief_summary>The purpose study determine antibiotic ceftaroline safe effective treatment community-acquired pneumonia adult .</brief_summary>
	<brief_title>Comparative Study Ceftaroline vs. Ceftriaxone Adults With Community-Acquired Pneumonia</brief_title>
	<detailed_description>Clinical trial hold different country . The purpose study determine antibiotic ceftaroline safe effective treatment community-acquired pneumonia adult .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Subjects communityacquired pneumonia requiring : initial hospitalization treatment emergency room urgent care set infection require initial treatment IV antimicrobial Communityacquired pneumonia suitable outpatient therapy oral antimicrobial agent Respiratory tract infection due communityacquired bacterial pathogen Infections resistant ceftriaxone Any condition require concomitant systemic corticosteroid History hypersensitivity allergic reaction ÃŸlactam antimicrobial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ceftaroline</keyword>
	<keyword>Community-acquired pneumonia</keyword>
	<keyword>CAP</keyword>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>Haemophilus influenzae</keyword>
	<keyword>Mycoplasma pneumoniae</keyword>
	<keyword>Chlamydophila spp</keyword>
	<keyword>Legionella ssp</keyword>
	<keyword>multi-drug resistant Streptococcus pneumoniae ( MDRSP )</keyword>
	<keyword>antimicrobial resistance</keyword>
	<keyword>pneumococcus</keyword>
	<keyword>beta-lactam</keyword>
	<keyword>ceftaroline fosamil</keyword>
	<keyword>ceftriaxone</keyword>
	<keyword>antibiotic</keyword>
</DOC>